Tianlong Industry Group Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

1993

Location

Shanghai China

Primary Industry

Pharmaceuticals

About

Founded in 1993 and based in Shanghai, China, Tianlong Industry Group is a medicine manufacture company that focuses on research and development of pharmaceuticals. The company has 10 production workshops, a central laboratory, and an animal experiment base. It passed GMP certification and produces 160 varieties of 8 dosage forms, of which 53 varieties are listed in the national basic medical insurance catalog. In February 2021, the company was fully acquired by Youcare Pharmaceutical Group Co., Ltd., a portfolio company of CITIC Goldstone Fund Management, HY Investment, Lyfe Capital, CITIC Securities, Dreamfly Capital for CNY 21 million. Tianlong Industry Group's main business category is pharmaceutical manufacturing. Products can be categorized into 7 series, which are cardiovascular, cerebrovascular, anti-infective, antipyretic and analgesic, immune system, digestive system and respiratory system. Products within include ten flavors cough tablets, diclofenac potassium capsules, azithromycin granules, and Chinese herbs.

Current Investors

Youcare Pharmaceutical Group Co., Ltd.

Request a demo to show more

Primary Industry

Pharmaceuticals

Sub Industries

Biopharmaceuticals, Pharmaceutical Research & Development

Verticals

Manufacturing

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.